Posted by Michael Wonder on 13 Dec 2021
EMA publishes agenda for 13-16 CHMP meeting
13 December 2021 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Aducanumab
- Pneumococcal polysaccharide conjugate vaccine (20 valent, adsorbed)
- Risperidone
- Finerenone
- Sitagliptin hydrochloride monohydrate with metformin hydrochloride
- Somatrogon
- Opicapone
- Voxelotor
- Enfortumab vedotin
- Lasmiditan
- Sapropterin dihydrochloride
- Tepotinib
- Vildagliptin with metformin hydrochloride
- Sotrovimab
- Linzagolix choline
